NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infection-Reference-Cited by-同舟云学术

NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infection

Published:2016-06 Issue: Volume:280 Page:89-96
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Libbey Jane E.,Hanak Tyler J.,Doty Daniel J.,Wilcox Karen S.,Fujinami Robert S.

Funder

NIH

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference55 articles.

1. Comparison of the effect of glutamate receptor modulators in the 6Hz and maximal electroshock seizure models;Barton;Epilepsy Res.,2003

2. Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures;Benkovic;Brain Res.,2004

3. Kainic acid-induced seizures and brain damage in the rat: different effects of NMDA- and AMPA-receptor antagonists;Berg;Pharmacol. Toxicol.,1993

4. Alterations in synaptic function in epilepsy;Bernard,2012

5. N-methyl-d-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy;Brandt;Neuroscience,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation of Cinnamon-Coated Cerium Oxide Nanoparticles and Evaluation of their Anticonvulsant Effect in Rats;Pharmaceutical Chemistry Journal;2023-08

2. Structure−Activity Relationship and Solubility Studies of N1‐Substituted Quinoxaline‐2,3‐diones as Kainate Receptor Antagonists;ChemMedChem;2023-07-20

3. Zika virus infection histories in brain development;Disease Models & Mechanisms;2023-07-01

4. Structural and interaction analysis of human lipocalin‐type prostaglandin D synthase with the poorly water‐soluble drug NBQX;The FEBS Journal;2023-04-11

5. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, modifies acute seizure burden and chronic epilepsy-related behavioral deficits following Theiler's virus infection in mice;Neuropharmacology;2023-01